The Royal Marsden NHS Foundation Trust shared on LinkedIn:
“The Royal Marsden has just delivered its 1000th online adaptive radiotherapy (oART) treatment with the Accuray Radixact linear accelerator (Linac) machine and RayStation software!
The pioneering advanced radiotherapy technology in Sutton is funded by The Royal Marsden Cancer Charity.
In 2024 The Royal Marsden became the first hospital in the world to treat a patient using this advanced radiotherapy planning system from RaySearch Laboratories.
The innovative technology enables clinicians to adjust a patient’s treatment plan on the same day, while the patient is on the treatment bed, based on changes in the patient’s anatomy.
Using this new technology, Dr Susan Lalondrelle, Consultant Clinical Oncologist and Dr Ben Thomas, Clinical Research Fellow in Adaptive Radiotherapy, with funding support from The Lady Garden Foundation, are leading the SHORTEN trial, a new study which is evaluating whether radiotherapy treatment for those with endometrial cancer can be reduced from 25 sessions over 5 weeks to just five sessions over one and a half weeks.
If the SHORTEN study is successful, this approach could be tested in a larger clinical trial, which could change radiotherapy duration for endometrial cancer patients.”
You can also read:
National Study Confirms Impact of NHS Lung Cancer Screening Programme – The Royal Marsden․